The ApiJect Story
Marc Koska’s solution to the syringe safety problem has the potential to greatly improve how pharma companies fill-finish medicines and vaccines around the world. Read Marc’s amazing journey.
Studio
One
Designing the Future of the Apiject Platform
The Apiject Platform can bring together Blow-Fill-Seal (BFS) containers and attachable delivery systems in an infinite variety of ways. At Studio One – Apiject’s design innovation center in London – a world-class team of device designers and engineers invent ways that BFS-based prefilled drug delivery systems can reliably and affordably deliver medicines that are needed by patients in a wide range of environments.
From intramuscular to intradermal, very small dose to large infusions, standardized to variable dosing, the team at Studio One is designing innovative ways for more drugs to reach more patients in a safe and reliable system.
Over the last 5 years, the Studio One team has produced hundreds of concepts and dozens of prototypes of prefilled injectors, all based on the Platform’s design principles of bringing together BFS containers and needle hubs.
The Studio One team is led by Marc Koska, OBE. Mr. Koska is the inventor of the K1 auto-disable syringe, and has been credited with saving more than 15 million lives by reducing the spread of iatrogenic infections from unsafe syringe use.
Studio One Expert Resources
The Benefits of Plastic Injection Molding
Co-Founder and Head of Product Development, Mac Koska, discusses using the latest in Injection Molding Tooling innovations, components can prototyped to a production quality level.
Celebrating the 40th Anniversary of the Invention of the K-1 Auto-Disabled Syringe
– Sterile and Safe Injection Breakthrough Has Saved More than 20 Million Lives – Stamford, CT; May 6, 2024 — ApiJect Systems, Corp., a medical technology public-benefit corporation, congratulates Marc Koska, Officer of the Order of the British Empire (OBE), ApiJect’s Co-Founder…
ApiLabs, R&D sister company to ApiJect, launches its Field Research Network
Geneva, Switzerland, September 15, 2022 – ApiLabs, an R&D company developing innovative, affordable medical technologies to maximize healthcare access for patients in all world regions, has launched its ApiLabs Field Research Network (AFRN). AFRN gathers qualitative and quantitative data from real-world settings…
Get in Touch!
Contact us today to learn more about Apiject and easy first steps to see if our Platform may be right for your sterile liquid product.